Christopher Bunick is a Dermatology physician affiliated with Yale University. OpenAlex indexes 276 publications with 3,000 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
20 York St
T-209
New Haven, CT 065103220
Telephone
203-688-2259Registry record last updated 15 May 2012.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- LEO Pharma Inc.Program year202553 payments$41,180openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year202530 payments$33,943openpaymentsdata.cms.gov ↗
- Takeda Pharmaceuticals U.S.A., Inc.Program year202514 payments$32,681openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2016–2025 per NIH RePORTER. The latest:
- Molecular function of an intermediate filament assembly mechanism in epidermal protein complexes and cell migration
Yale University
FY2025$357,445R01AR079428 - Molecular function of an intermediate filament assembly mechanism in epidermal protein complexes and cell migration
Yale University
FY2024$357,445R01AR079428 - Molecular function of an intermediate filament assembly mechanism in epidermal protein complexes and cell migration
Yale University
FY2023$368,500R01AR079428
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Biologic Therapies Targeting Type 2 Signaling in Atopic Dermatitis: A Comparative Review of Structural and Thermodynamic Differences in Mechanism of Action
Journal of Investigative Dermatology
2025 - Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis
American Journal of Clinical Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Thomas McGlashan, MD
Yale University
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”